Acacia Announces Commencement of Rights Offering
Acacia Research Corporation (NASDAQ: ACTG) has initiated its Rights Offering, granting non-transferable subscription rights to eligible securityholders holding common stock as of February 13, 2023. Each eligible holder will receive one subscription right for every four shares owned, allowing them to purchase an additional share at $5.25 until March 1, 2023. Starboard Value LP, a strategic investor, is also entitled to similar private rights in a concurrent offering. The proceeds from the Rights Offering aim to enhance Acacia's financial stability and support its acquisition strategy. The offering is contingent upon the concurrent private rights offering's completion.
- Rights Offering provides current shareholders an opportunity to purchase additional shares at a set price of $5.25 each.
- Proceeds from the offering will strengthen financial position and fund acquisitions.
- Potential dilution of existing shareholders' equity if rights are exercised.
- Dependence on successful completion of the concurrent private rights offering.
Under the terms of the Rights Offering, the Company will distribute non-transferable subscription rights to record holders (“Eligible Securityholders”) of the Company’s common stock (the “Common Stock”) held as of
Pursuant to the Rights Offering, Eligible Securityholders will receive one non-transferable subscription right (a “Subscription Right”) for every four shares of Common Stock owned by such Eligible Securityholders. Each Subscription Right entitles an Eligible Securityholder to purchase, at such Eligible Securityholder’s election, one share of Common Stock at a price of
Acacia intends to use the net proceeds for general corporate purposes, including to strengthen its financial position and to serve as capital for its acquisitions platform.
Other Important Information
The Rights Offering will be made pursuant to the prospectus supplement to the Company’s shelf registration statement on Form S-3 (No. 333-249984), filed with the
The information herein, including the terms of the Rights Offering and the Concurrent Private Rights Offering, is not complete and is subject to change. The Company reserves the right to amend, extend, terminate or cancel the Rights Offering and/or the Concurrent Private Rights Offering or modify the subscription period of the Rights Offering at any time prior to the Expiration Time for any reason. This press release does not constitute an offer to sell or the solicitation of an offer to buy any subscription rights or any other securities to be issued in the Rights Offering, Concurrent Private Rights Offering or any related transactions, nor shall there be any offer, solicitation or sale of Subscription Rights or any other securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Copies of the prospectus and prospectus supplement will be mailed to all Eligible Securityholders and may also be obtained free of charge at the website maintained by the
Forward-Looking Statements
This communication contains forward-looking statements within the meaning of the federal securities laws, including statements about our intention to conduct the Rights Offering and Concurrent Private Rights Offering, which statements are subject to substantial risks and uncertainties. These forward-looking statements are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this communication, or incorporated by reference into this communication, are forward-looking statements. Throughout this communication, we have attempted to identify forward-looking statements by using words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecasts,” “goal,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” or other forms of these words or similar words or expressions or the negative thereof, although not all forward-looking statements contain these terms. Forward-looking statements address future events and conditions concerning, among other things, our intention to conduct the Rights Offering and Concurrent Private Rights Offering, acquisition and development activities, financial results of our acquired businesses, intellectual property, or IP, licensing and enforcement activities, other related business activities, the impact of the COVID-19 pandemic, capital expenditures, earnings, litigation, regulatory matters, markets for our services, liquidity and capital resources and accounting matters. Forward-looking statements are subject to substantial risks and uncertainties that could cause our future business, financial condition, results of operations or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this communication. All of our forward-looking statements include assumptions underlying or relating to such statements that may cause actual results to differ materially from those that we are currently expecting, and are subject to numerous factors that present considerable risks and uncertainties, including, without limitation: our ability to consummate the transactions contemplated by the Recapitalization Agreement, dated as of
We caution that the foregoing list of important factors that may affect future results is not exhaustive. You should not rely on forward-looking statements as predictions of future events. Except as required by law, we undertake no obligation to publicly update or revise any forward-looking statements or information, whether written or oral, that may be as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230213005670/en/
Investor Contact
FNK IR
actg@fnkir.com
Source:
FAQ
What is the subscription price for Acacia Research's Rights Offering?
When does the Rights Offering for ACTG expire?
Who is eligible to participate in the ACTG Rights Offering?
What are the intended uses for the proceeds from the ACTG Rights Offering?